NOV-002
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for NOV-002, covering 2012-07-30 to 2022-07-25. Get the full timeline:
Most recent: Clinical Trial Update: Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer [Phase 3]